3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Bacterial Infections
1
Agammaglobulinemia
1
Interventions
Specimen Handling
308
Magnetic Resonance Spectroscopy
265
pembrolizumab
254
Carboplatin
185
Cyclophosphamide
180
Biopsy
168
Cisplatin
157
Gemcitabine
136
Paclitaxel
131
Bevacizumab
125
fludarabine
118
Nivolumab
111
Radiotherapy
109
Oxaliplatin
88
Docetaxel
88
Fluorouracil
85
Capecitabine
84
venetoclax
78
Dexamethasone
77
Pemetrexed
73
Rituximab
70
Leucovorin
69
Drug Therapy
69
durvalumab
67
atezolizumab
67
Radiosurgery
65
Blood Specimen Collection
65
Standard of Care
64
Doxorubicin
64
Radiation
60
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
gamma-Globulins
×
90 days
×
Clear all
NCT05645107
2026-04-13
EXCELL
Grifols Therapeutics LLC
Phase 3
Recruiting
386 enrolled